High-power Green-light Laser Endoscopic Submucosal Dissection for Non-muscle-invasive Bladder Cancer

NCT05290623 COMPLETED

A retrospective study was designed in this study. The surgeon performed high-power green-light laser endoscopic submucosal dissection (HPL-ESD) for the treatment of primary non-muscle-invasive bladder cancer (NMIBC). This surgical treatment was novel and safety and efficacy of the treatment has not been established. We collected relative data in Shandong Provincial Hospital Affiliated to Shandong First Medical University from May 2018 to December 2020. Preoperative, intraoperative and postoperative clinical data were collected and analysed. The safety and efficacy of the novel surgical treatment were verified by the short-term and long-term clinical outcomes. Fifty patients with NMIBC were planed to be enrolled in the study.

Details

Lead sponsor	Shandong Provincial Hospital
Status	COMPLETED
Enrolment	45
Start date	Tue May 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Mar 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Bladder Cancer

Countries

China